Primary Topic
This episode delves into the remarkable biological adaptations that prevent bone loss in breastfeeding mothers, despite high calcium demands during lactation.
Episode Summary
Main Takeaways
- Breastfeeding increases calcium demands, which should theoretically weaken bones, but a special protein prevents this.
- Gene-editing tools like CRISPR Cas are being adapted to modify gut bacteria directly, which could impact overall health including bone density.
- Advanced gene-editing techniques have successfully targeted specific genes in gut bacteria of mice, potentially paving the way for human applications.
- The episode emphasizes the complexity of the gut microbiome and the challenges of delivering gene-editing tools to the right targets within it.
- The potential implications of these findings are vast, including better management of bone diseases and more effective antibiotic resistance strategies.
Episode Chapters
1: Introduction to Bone Health and Breastfeeding
Overview of how estrogen levels typically support bone health and the puzzle of maintaining bone density during breastfeeding when estrogen levels drop. Includes discussions on the biological mechanisms involved. Nick Petrillo: "How are bones maintained during breastfeeding, a time when demands for calcium are particularly high? More on that later."
2: Gene-Editing in Gut Bacteria
Detailed discussion on new gene-editing techniques that allow precise modifications in gut bacteria, potentially improving health outcomes. Gemma Conroy: "This system can be adapted and back to mice."
3: The Role of a Special Protein in Bone Health
Exploration of a specific protein that plays a crucial role in maintaining bone strength during the intensive calcium extraction of breastfeeding. Holly Ingram: "This is the protein that is really having a huge effect on bone."
Actionable Advice
- Increase dietary calcium intake during breastfeeding to support bone health.
- Stay informed about new scientific developments in bone health, especially those related to pregnancy and lactation.
- Discuss any concerns about bone density with a healthcare provider, especially when planning for or currently breastfeeding.
- Consider participating in clinical studies if available, to contribute to advancing bone health research.
- Monitor and maintain general health through regular exercise and a balanced diet to support bone density.
About This Episode
Researchers have developed a method to directly edit the genes of specific bacteria in the guts of live mice, something that has previously been difficult to accomplish due to the complexity of this environment. The tool was able to edit over 90% of an E. coli strain colonising mice guts, with other work showing the tool could be used to edit genes in pathogenic bacterial species and strains. It is hoped that with further research this technique could be adapted to work in humans, potentially altering bacteria associated with disease.
People
Nick Petrillo, Gemma Conroy, Holly Ingram
Companies
None
Books
None
Guest Name(s):
None
Content Warnings:
None
Transcript
Nature Podcast
The Nature podcast is supported by Nature Plus, a flexible monthly subscription that grants immediate online access to the science journal Nature and over 50 other journals from the Nature portfolio.
More information at go dot nature.com plus.
Us Cellular
Ever heard of test driving a phone network? Well, us cellular is letting you test drive their nationwide 5g for free.
Us Cellular
Try out us cellular wherever you have spotty service, commute to work. Or maybe that one spot in your house where your service just dips like the back corner of our bedroom.
Us Cellular
It's as easy as doing a little me pop on your phone.
Us Cellular
What was that?
Us Cellular
That was me getting the app. Like that's me to try it out. Cause I'm good with sound effects. That's what it sounds like.
Us Cellular
Okay, test drive Us Cellular's nationwide 5g coverage for free for 30 days. Just download the try us app.
Us Cellular
Us cellular built for us terms apply. Visit uscellular.com tryuse.
Unknown
In an experiment why.
Unknown
Is blight so far?
Unknown
It sounds so simple.
Unknown
They had no idea.
Unknown
But now the data. I find this not only refreshing, but at some level, astounding.
Nature welcome back to the Nature podcast. This week, a new way to edit genes in gut bacteria and a hormone.
Nick Petrillo
That builds bone during breastfeeding. I'm Nick Petra Chow.
Unknown
And I'm Benjamin Thompson.
As we've covered on the podcast before, the bacteria that live in the human gut have been shown to play an important role in how our bodies operate, and disrupting them can have serious health implications.
But the gut is absolutely teeming with bacteria, different strains, different species and so on. So working out which one or ones are responsible for various outcomes has been really difficult to tease out. But that might be about to change. This week, a team have a paper out demonstrating a method to directly edit the genomes of specific bacteria in the guts of mice. Gemma Conroy, senior reporter for the Asia Pacific region, has been covering the story for nature, and she joins me on the line from Sydney. Gemma, thanks for being on the show.
Unknown
Thanks so much for having me.
Unknown
Let's start by talking about why it's been so hard to kind of home in and make changes to specific bacteria in the gut. Because gene editing tools like CRISPR Cas, which is itself microbially derived, of course, have been in the lab for a good long while. So why has this been such a difficult thing to achieve?
Unknown
So it's not so much editing the bacteria, it's being able to access bacteria in the gut. The gut is such a complex environment, as you mentioned, teeming with trillions of microbes, and it's just been really difficult to sort of find a tool or develop a tool that can actually directly access these microbes in the gut. We've had some systems, like CRISPR Cas systems, have been used to selectively kill bacteria carrying harmful genes, but this can increase the risk of microbes developing resistance.
And then you have base editors which have classically been delivered inside bacteriophages, which are viruses that infect bacteria. And base editing, by the way, is an editing tool that swaps one nucleotide base to another. So it's like converting an a to a t, for example. But these approaches have often failed to modify enough of the target bacteria population. So it hasn't been super effective. It's just, it's really difficult to do. It's a very hard environment to access.
Unknown
So then it's not necessarily editing the genes. That's been the difficult bit. It's been actually delivering the gene editing machinery, whatever it is, to the correct bacteria in the gut. And that's what this paper then has overcome. And you mentioned bacteriophage there, these little viruses, and it seems like they've had taken some of the abilities of these phages to deliver a gene editing tool.
Unknown
Yeah, they engineered a vector out of components of bacteria phage, so it wasn't a natural bacteriophage. They sort of took elements of one to home in, specifically on E. Coli. And this vector carried a base editor that targeted specific genes in E. Coli. And they also managed to refine the system. Because another concern with any kind of editing is that the edited genes would end up replicating and spreading to places where they shouldn't be. But they managed to engineer this base editor to sort of prevent those edited genes from replicating.
Unknown
Okay, so they have this phage derived system then, that really can home in and deliver this base editor into this population of E. Coli in the mouse gut. How effective was it? Like, did it work as intended?
Unknown
So when they delivered the system to mice and they tweaked the system so it would target an E. Coli gene that produces beta laptamases, which are enzymes that drive bacterial resistance to several kinds of antibiotics. Some 8 hours after mice received that treatment, I think it was around 93%. The targeted bacteria had been edited.
Unknown
So 93%, on the face of it, is quite a high number. Then how does this compare to previous efforts to edit genes inside an animal's gut?
Unknown
I think this is like the first time it's worked as well as it has. They were able to edit almost all of the colony in the gut.
Unknown
So it says that in mice on this one strain of E. Coli then. But I guess, of course, the bacterial kingdom, as we know, is enormous, and there's a bunch of different sorts of bacteria. Is this system applicable to others? Did they show anything else in that respect?
Unknown
So, in the lab, the researchers also used the tool to edit different strains via colo, and they also tried it out on another species of bacteria that causes pneumonia infections. And they were able to still effectively edit these strains and this different spectrum, which suggests that this system can be adapted and back to mice. They also use the base editor to edit the E. Coli gene that produces this protein that drives bacterial colonization in the gut. And it's also thought to play a role in several neurodegenerative and autoimmune diseases. And they found that when they targeted this particular gene, the proportion of edited bacteria in mice hovered around 70%, even three weeks after they were treated.
Unknown
And as we've said, this in general has been quite a difficult thing to do. What are folks saying about this work?
Unknown
Well, one researcher I spoke to said that this base editing system represents a critical leap forward in terms of developing editing tools that can modify bacteria directly inside the gut. That seems to be a key point of difference here. We're not just dealing with bacteria in a dish in a lab, but in a really complex environment.
And that opens the possibility of editing. Microbes combat disease and ensuring as well that the modified DNA doesn't spread and lead to detrimental effects.
Unknown
But, of course, it's worth double underlining. We so often do this work was done in mice or in a dish in the lab. Do the researchers think it will be applicable to humans? What are the next steps to try and find out if it is?
Unknown
I think a key thing is designing vectors that can be used in different models and different species, including humans, and that will kind of be the next step. And it's also about tweaking the system as well, so it can target different bacterial. As you said before, it's not just E. Coli. So I think that would be a big next step.
Unknown
Nature's Gemma Conroy there to read her news article on the new paper and to read the paper itself. Look out for links in the show notes.
Nick Petrillo
Coming up, how are bones maintained during breastfeeding, a time when demands for calcium are particularly high? More on that later. Right now, though, it's time for the research highlights. And we have a new voice on the podcast, Emily Bates.
Unknown
It turns out performing life saving surgery is not something only humans can do, as some ants have been amputating their nest mates legs to save lives.
To reduce the risk of infection, some ant species make antimicrobial compounds that they apply to nest mates wounds. But other species, including the Florida carpenter antennae, have lost this ability. To understand how these insects handle wounds, researchers injured the legs of worker ants and studied their nest mates reaction.
When the injury was at the end of the leg, the insects focused on caring for the wound. But when an ants leg was injured close to the body, nest mates amputated the leg by biting it off, suggesting these ants can select their treatment method based on where the wound is located.
Sink your teeth into that paper in current biology.
For much of human history, amber was a prized commodity associated with power and wealth.
So much so that in the neolithic period, people would make fakes.
Previous work has shown that amber was scarce in Spain during this period, and researchers have found a handful of look alikes among genuine amber beads in the region.
So scientists have now analyzed the simulated amber beads and found that most consisted of mollusk shells that had been coated in pine resin, mixed with beeswax and a natural orange red pigment, giving the items a smooth, amber hued finish and making them a substitute for the real thing.
You can read the full study in the Journal of Archaeological Science.
Nick Petrillo
Theres a bit of a mystery when it comes to bones.
How are they maintained while breastfeeding? You see, ordinarily, the hormone oestrogen keeps the bones healthy by maintaining bone formation and preventing them from being broken down.
But estrogen levels drop precipitously during lactation, a time when demands on the bones are incredibly high to get enough calcium to make milk. During breastfeeding, bones are stripped of the mineral.
And while bone loss does occur during this time, mostly people are able to breastfeed without their bones completely eroding away, but without estrogen. How is this accomplished?
Well, there are some clues. In previous studies, a few years ago, a team found that deleting a certain gene in female mice led to them having unusually strong bones. But exactly how this happened wasn't clear.
Now, though, the same team have gotten to the bottom of it and discovered a protein that gets produced during lactation that is central to building bone.
To find out more about this protein, I called up one of the authors, Holly Ingram. She told me that they were pretty sure it was circulating in the blood, but finding out what exactly it was was a whole other challenge.
Holly Ingram
Well, so after, you know, various things, you know, trying to set up a standard biochemical assay, which did not work, trying to do mass spec, which did not work, I forget what else we tried.
We tried almost everything we could think of, but it was actually when Muriel Bebe, who's one of the lead, along with William Krause, she came to the lab. She decided to put these mutant mice on a high fat diet. I mean, we knew that high fat diet may change the activity of these neurons, but we had no idea that what it was going to do, which is that when we put these mice on a high fat diethye, we lost the bone phenotype. And then we basically had a hook to figure out, okay, what are the gene changes that occur in the body of these mutant mice? And we found a set of genes were changed, and we narrowed it down to two.
And then it turned out that the gene that was responsible or encoded the protein that was responsible for this phenotype, was this protein called cellular communication network three, dcm three. And then we showed in many, many ways that this is the protein that is really having a huge effect on bone.
Nick Petrillo
And can you describe for me a couple of the ways that you showed this? Did you reduce the amount of this that the mice had, increase it, that sort of thing, to sort of show the effects?
Holly Ingram
Right? So we did sort of that classic, let's get rid of it in this mutant mice, which we did, and we saw that the bone was lost, or let's take wild type control mice and let's over express this. And then when we did that, we found that bone formation, bone volume, bone strength, all increased. So we came at this multiple ways. And then we also worked with my co lead, which is Tom Ambrosi. He did an experiment with his collaborators where they took two year old male mice. So these are pretty feeble old gentlemen, as we would call them, and they do a fracture on these femurs. And then what he did is he took CCN three in a slow release gel, so it just releases slowly over time. And then he looks at fracture repair. So what was amazing is that the fracture repair was accelerated and improved in these two year old mice. And really, when you look at it, they look like a fracture repair of a two month old mouse. You're really rejuvenating this whole system.
So when I saw that data, I said, this is real.
I believe it.
Nick Petrillo
It's interesting, though, as well, because, like you say, this was in male mice, and you wouldn't have thought that this hormone, this protein, would be something that they would really, you know, be dealing with.
Holly Ingram
Well, okay, so that's the other beautiful thing about this project, is that this is a female specific hormone, and we'll talk about when it comes on in normal females during lactation. But what is really beautiful about this is it works on both male and female bone. So the female specificity is just where it's being made and when it's being made by the female brain.
But it's an equal opportunity hormone, so it works on both males and females, which is fantastic.
Nick Petrillo
So, yeah, maybe that we can talk about that, though. So what do you think this hormone is doing? Like, how does it play out in the normal lactation cycle?
Holly Ingram
Right. So after identifying CCM three as the hormone that was responsible for the Sibon phenotype, these mutant mice, we then asked, well, is this relevant? Is this relevant to any physiology normally in female mice? So we looked at every stage possible, and again, thinking, oh, well, maybe it comes on after weaning, because we know that bone builds up after weaning, and we were really surprised that this hormone comes on right during lactations. So a little bit right after birth, this hormone appears in the brain. It comes on like gangbusters. And so then you go back to the literature. This is where I tell young people, read, read the old literature. You're not the first to have discovered something. And so that's what we ended up doing. And we found some amazing literature from 20 years ago and even longer that it's been known that during lactation, bone formation is up, but the net result is bone loss, because you're absorbing it to strip calcium off.
Nick Petrillo
Right. So during lactation, bones are being stripped for calcium, and without estrogen, you'd expect them to be completely broken down. But this hormone is kind of stepping up to the plate and preventing this from happening.
Holly Ingram
Exactly. And so you need a way of ensuring that you don't just crumble into nothingness when you're breastfeeding.
Nick Petrillo
And I guess the other thing I was wondering as well is your study was obviously focused on these mouse models. You have done a bit of work with human cells as well, but do you think the same thing happens in humans?
Holly Ingram
Well, that's a wonderful question. And Muriel Babet, who is an adult endocrinologist, I think is going to be working with some clinical people once we can get samples. And this stuff is really hard to detect in the blood because there's not really good reagents right now, which is the other thing we're trying to do. But I think once we get those reagents, that's one of the first questions. Is this relevant to humans? I'm going to guess, yes.
But that has yet to be proved.
Nick Petrillo
So you've got an idea of what role this hormone plays during breastfeeding. But I wonder what you think are the broader implications of this finding. There are a lot of diseases that affect bones, things like osteoporosis, where bones become weaker. Could this hormone be potentially something that people could look to?
Holly Ingram
Right. So I think that in terms of the translational aspects of this, I do think hopefully we'll get there someday. We hope that we can, because this is a natural hormone, very much like a GLP, one that has now been used for obesity.
You know, I'm hoping with new technology, we could really see if this can be translated. And I do think that the fracture repair data suggests that it looks promising. And I also think that it. There was just an article in the Washington Post describing a woman that had lactational osteoporosis, which can be really severe. And so one wonders whether part of this whole pathway is disturbed in women like that, so that they're fine until they get challenged with this pregnancy and lactation. And so the question is, are we going to find variants of this pathway in women like that, that are susceptible to lactational osteoporosis?
Nick Petrillo
That was Holly Ingram of the University of California, San Francisco in the US.
For more on that story, check out the show notes for some links.
Unknown
Finally on the show, it's time for the briefing chat, where we talk about a couple of stories that have been highlighted in the nature briefing. Nick, why don't you go first this week? What have you got?
Nick Petrillo
So this week I've been reading a story that's reported on in nature about a science paper looking at the sort of root cause of migraines.
Unknown
Right now. I must say I've never had a migraine, but I know a lot of people who have, and they sound absolutely awful and can be debilitating in many cases. And I think, yeah, a bit of a mystery as to what's going on. Right?
Nick Petrillo
Yeah, it's a bit of a mystery because one of the things that's really unclear is how things happening in the brain lead to pain, because the brain, as you know, doesn't actually have any pain receptors. That's why if you've ever seen, like, a surgery on someone's brain, they can do it without putting them under anesthesia. So what's going on within the brain to cause pain? Because it's not the brain itself. And so this study, which is another study in mice, it seems to be a bit of a theme of the show this week, they've looked at a particular type of migraine called an oral migraine. I don't know if you've familiar with this, but an oral migraine is where you have an aura preceding the migraine. So this is where you have sensitivity to light. You have, like, dark spots and other stuff going on. But the key thing for this is you have sort of a blackout during it. So neuronal activity shuts off for a short amount of time, and then the migraine comes. So that's the one they've been investigating here.
Unknown
Right. So there's kind of a tell that it's about to start, and then the pain kicks in. Right. So tell me how.
And some unusual stuff going on in the brain of these mice, then what did the researchers find specifically?
Nick Petrillo
So what they found was happening is when this blackout occurred to, there were changes to the cerebrospinal fluid. So this is the fluid that sort of surrounds the spine and the brain. And what seems to be happening here is this neuronal blackout seems to proceed like changes to the cerebrospinal fluid. So changes in protein, specifically. So some proteins really jump up in the number that are present, and some proteins really drop down. And one in particular that jumps up is one called CGRP, which is known to transmit pain and has previously been a target of sort of migraine therapies. So a lot changing in the cerebral spinal fluid.
Unknown
Right. And presumably, then this has knock on effects on pain neurons elsewhere in the body.
Nick Petrillo
Well, what is unusual here is they've actually uncovered, like, a previously unknown part of the anatomy. So there is actually a little gap, and it's at this area known as the trigeminal ganglion, which is like a bunch of nerves at the base of the skull, wherever the cerebral spinal fluid can sort of come in and maybe having its effects. And this trigeminal ganglion, this is a center for sort of transmitting pain and other sensory information. So the researchers believe what is happening here is some of these proteins, these changes in the proteins are causing an effect on this area, and then that is leading to pain.
Unknown
And so it seems like in mice, at least, as you say, this is giving an insight into maybe the biochemistry, I suppose, and the molecular biology underlining this particular type of migraine. Any idea of whether this might translate into humans? I guess there are people who will be crying out for treatments for migraine.
Nick Petrillo
Yeah, well, that remains to be seen. So the key thing will be trying to identify what proteins may be changing here and then seeing what effects they have. And there will obviously be future studies that would involve humans to sort of figure this out and maybe see if certain proteins could be blocked or that sort of thing to help it. But the interesting thing, according to some of the researchers who were interviewed for this article, is that this shows that a change in the brain is then preceding pain, which could be like a link between the two, which has previously been unknown. And the other big question for researchers as well is why is this causing a headache? As I said, this trigeminal ganglion, it's like a core center for sensory information. So why are we just getting a headache? Why not pain everywhere and that sort of thing? So, a lot more questions for this one, but certainly answers at least some that have long puzzled scientists.
Unknown
Well, definitely one to follow, and fingers crossed, then, that something useful can be found that can translate to help people in the future. But let's move on to my story this week, Nick, and it couldn't be more different. And it's about fashion. Now, you and I are both incredibly well dressed podcast hosts. Listeners can't see it, but here we are in our immaculately cut italian suits. Not sure about your top hat, but let's leave that be. And I know that fashion is central to our brand. Right. I know something else that's central to our brand, and that's recycling. Right. And I've got a story here that combines both of them.
Nick Petrillo
Right, okay. So I've heard the term fast fashion to describe the sort of waste associated with fashion. I'm assuming if this is about recycling, this is something to maybe help the sort of waste that accumulates with the industry of fashion.
Unknown
Yeah, well, absolutely. Right. Estimates suggest that less than 1% of clothes are recycled, and nearly three quarters of garments either end up just incinerated or in landfill. And that can have knock on effects for things like microplastics from synthetic fibres getting into waterways and all the other sort of stuff that we've covered on the podcast. But researchers are trying to work out if they can improve recycling. And so this is a story I read about in nature, and it's based on a paper in scientific advances. Now, one of the issues with recycling clothes is the fact they're often a blend of materials, cotton and polyester, say. Now, if you think about recycling, you often have to separate out the individual things, right? Maybe at home you separate out your cans from your glass, that sort of thing. But when the materials are actually kind of woven or stitched together, that can be really, really difficult. And mechanical recycling techniques struggle to separate multi fiber textiles. And so researchers have turned to chemistry to try and crack this knot.
Nick Petrillo
Okay, so, I think, you know, we've covered on the podcast before, maybe sort of like enzymes and that sort of thing to break down plastics. Is this something like that?
Unknown
Slightly different. So it doesn't use enzymes. It does use a catalyst and heat and a technique called microwave assisted glycolysis. And what this does is it breaks down large chain polymers into smaller units. Right. Which is kind of what we want. And those smaller units can be reused.
Now, in this paper, the team tested it on fabrics that were either 100% polyester or 50 50 poly cotton. And what they showed is, with pure polyester, the reaction converted over 90% of the material into a molecule called bhet, which can be reused to make more polyester. But what's neat is, for the mix, the process doesn't touch the cotton. Right. So the polyester is broken down and leaving the cotton behind. And the cotton can be recycled in its own way. That's often shredded up and used to make new fibers. So you've got this thing that is quite inherently linked, but the team have managed to unstitch it, if you will, to try and put individual materials down different recycling paths.
Nick Petrillo
And did they try this on other fabrics and things? Because I guess there's more than polyester and cotton that make up many cloves.
Unknown
Yeah, absolutely. Right. And they tried it with different combinations. Okay. So the results seemed positive when they just tried essentially, like, a random group of garments. Right. That contained unknown proportions of fibers, including cotton, polyester, nylon, or elastane, which is sometimes known as spandex. Okay. And they used their system, and the spandex broke down into a useful molecule called MDA, and the polyester broke down as before. So they showed that they could once again, sort of split these things off. And what's neat about this is that it's quick. Okay. The team optimized this. So in some cases, only takes 15 minutes to do the job. Right. So quite cost effective, because one of the researchers involved in this work said that typically, it can take days to break down some of these synthetic materials. And he says that eventually, potentially, they can get it down to seconds.
Nick Petrillo
Whoa. Okay, that does sound very quick. But I guess with my sort of sensible top hat on, how are they going to translate this into something we can use in the real world? I'm assuming this is just sort of testing at the moment.
Unknown
I mean, yes, that's always the case. What's interesting, though, is that they've done some analysis, and they calculate that maybe this process could allow 88% of clothing worldwide to be recycled. So, you know, you need less time to sort it. It's a relatively simple process. I think the researchers themselves say if it could be taken up in the real world. But of course, there are some caveats. Some polyesters don't break down so well, maybe if they've been dyed or if they've been treated to be resistant to uv or fire. So there's a little ways to go. And it is a proof of concept. But what goes without saying, and what one researcher quoted in the article does say, is that repairing and reusing really should be sort of the key weapons in the fight against this textile waste. But this could be a useful addition.
Nick Petrillo
Well, this does sound like it could be incredibly useful if perfected. And, you know, some of these caveats are overcome. But for now, I think that's all we've got time for on the briefing chat and listeners. For more on those stories and for where you can sign up to nature briefing to get more like them, check out the show notes for some links.
Unknown
As always, you can keep in touch with us on x. We're at Nature podcast. Or you can send us an email to podcastature.com. i'm Benjamin Thompson.
Nick Petrillo
And I'm Nick Bertraccel. Thanks for listening.
Nature Podcast
Deep dive into the world of science with nature. Plus, from the vastness of the distant star systems to the intricacies of infectious diseases due to climate change, we've got you covered. Enjoy access to over 55 cutting edge journals, breaking scientific news, and over a thousand new articles every month. Whether you're a seasoned researcher or just curious, natureplus simplifies complex studies. Plus, it's all available right at your fingertips on nature.com.
nature, the key to unlocking the world's most significant scientific advances. Subscribe today at go dot nature.com plus.
Us Cellular
Ever heard of test driving a phone network? Well, us cellular is letting you test drive their nationwide 5g for free.
Us Cellular
Try out us cellular, wherever you have spotty service, your commute to work. Or maybe that one spot in your house where your service just dips like the back corner of our bedroom.
Us Cellular
It's as easy as doing a little me pop on your phone.
Us Cellular
What was that?
Us Cellular
That was me getting the app. Like that's me to try it out. Cause I'm good with sound effects. That's what it sounds like.
Us Cellular
Okay, test drive us cellular's nationwide 5g coverage for free for 30 days. Just download the Tryus app us cellular.
Us Cellular
Built for us terms apply. Visit uscellular.com tryuse.